Skip to main content
SpringerLink
Log in

Outcome and tolerability of topiramate in brain tumor associated epilepsy

  • Clinical-Patient Studies
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Epilepsy in brain tumor patients is often refractory to pharmacological treatments and can complicate the therapeutic management of these patients. We conducted a prospective, observational study. The aim of this study was to investigate the efficacy and tolerability of topiramate (TPM) in brain tumor associated epilepsy. We studied 47 patients with brain tumors and epilepsy. The entire group was administered AEDs. TPM was the first therapeutic choice in 14 patients, while in the remaining 33 patients previous AEDs were modified and TPM was introduced due to side effects or inefficacy of the first drug. Follow-up ranged from 3 to 48 months (mean 16.5 months). Considering the final follow-up of each patient who assumed TPM for at least 3 months, we observed 45 patients: 25 were seizure free (55.6%), 9 had a reduction of seizure frequency (SF) higher than 50% (20%) and 11 were stable (24.4%). TPM responder rate was 75.6%. Three patients (6.4%) discontinued TPM for severe side effects (1 after 4 months and 2 after 1 month) and 4 (8.5%) had mild and reversible side effects. In the group of patients who had been in therapy with other AEDs prior to entering the study (n = 33), 19 patients had side effects (57.6%). During follow-up, the haematological parameters were in the normative ranges. Tumor-related seizures are difficult to control with AEDs; the precise reasons for this difficulty are not yet clear. Using TPM, we obtained good seizure control with a low incidence of side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. De Angelis L (2001) Brain tumors. N Engl J Med 344:114–123

    Article  Google Scholar 

  2. Hwang SL, Lin CL, Lee KS, Lieu AS, Kuo TH, Chang CZ, Yen CP, Lin CK, Loh JK, Huang TY, Howng SL (2004) Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir 146:589–594

    Article  Google Scholar 

  3. Lote K, Stenwig AE, Skullerud K, Hirschberg H (1998) Prevalence and prognostic significance of epilepsy in patients with gliomas. Eur J Cancer 34(1):98–102

    Article  PubMed  CAS  Google Scholar 

  4. Luyken C, Blumcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J (2003) The spectrum of long term epilepsy-associated tumors: long term seizure and tumor outcome and neurosurgical aspects. Epilepsia 44(6):822–830

    Article  PubMed  Google Scholar 

  5. Mason WP. (2003) Anticonvulsant prophylaxis for patients with brain tumors: insights from clinical trials. Can J Neurol Sci 30:89–90

    PubMed  Google Scholar 

  6. Hildebrand J (2004) Management of epileptic seizures. Curr Opin Oncol 16:314–317

    Article  PubMed  Google Scholar 

  7. Schaller B, Rüegg SJ (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 44(9):1223–1232

    Article  PubMed  Google Scholar 

  8. Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52:717–724

    PubMed  CAS  Google Scholar 

  9. Wen PY, Marks PV (2002) Medical management of patients with brain tumors. Curr Opin Oncol 14(3):299–307

    Article  PubMed  Google Scholar 

  10. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54:1886–1893

    PubMed  CAS  Google Scholar 

  11. Temkin NR (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42(4):515–524

    Article  PubMed  CAS  Google Scholar 

  12. Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404–409

    Article  PubMed  CAS  Google Scholar 

  13. Vecht CJ, Wagner GL, Wilms EB (2003) Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol 30(9):49–52

    Article  PubMed  CAS  Google Scholar 

  14. Bourgeois Blaise FD (1999) Pharmacokinetics and metabolism of topiramate. Drugs of Today 35(1):43–48

    Google Scholar 

  15. Anderson GD (2004) Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63(4):S3–S8

    PubMed  CAS  Google Scholar 

  16. Bialer M, Doose DR, Murthy B, Curtin C, Wang SS, Twyman RE, Schwabe S (2004) Pharmacokinetic interactions of topiramate. Clin Pharmacokinet 43(12):763–780

    Article  PubMed  CAS  Google Scholar 

  17. Nallani SC, Glauser TA, Hariparsad N, Setchell K, Buckley DJ, Buckley AR, Desai PB (2003) Dose-dependent induction of Cytochrome P450 (CYP) 3A4 and Activation of Pregnane X Receptor by Topiramate. Epilepsia 44(12):1521–1528

    Article  PubMed  CAS  Google Scholar 

  18. Beghi E. (2004) Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 3:618–621

    Article  PubMed  CAS  Google Scholar 

  19. Patsalos PN, Froscher W, Pisani F, Van Rijn CM (2002) The importance of drug interactions in epilepsy therapy. Epilepsia 43(4):365–385

    Article  PubMed  CAS  Google Scholar 

  20. Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79(12):1489–1494

    PubMed  Google Scholar 

  21. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD. Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA (2004) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology 62:1261–1273

    PubMed  CAS  Google Scholar 

  22. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R (2003) Differential cognitive and behavioural effects of topiramate and valproate. Neurology 60:1483–1488

    PubMed  CAS  Google Scholar 

  23. Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB (2005) Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 64:792–798

    PubMed  CAS  Google Scholar 

  24. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198

    Article  PubMed  CAS  Google Scholar 

  25. Karnofsky DA, Burchenal JH, Armistead GC, Southam CM, Berstein JL, Craver LF, Rhoads CP (1951) Triethylene melamine in the treatment of neoplastic disease. Arch Int Med 87:477–516

    CAS  Google Scholar 

  26. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events v3.0, DCTD, NCI, NIH, DHHS, December 12, 2003 (http://ctep.cancer.gov)

  27. Brada M, Viviers L, Hines F, Britton J, Ashley S, Sardell S, Traish D, Gonsalves A, Wilkins P, Westbury C (2003) Phase II of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715–1721

    Article  PubMed  CAS  Google Scholar 

  28. Prados MD, Scott C, Curran WJ Jr, Nelson DF, Leibel S, Kramer S (1999) Procarbazine, lomustine and vincristine (PCV) chemotherapy for anaplastic astrocytoma. A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. J Clin Oncol 17:3389–3395

    PubMed  CAS  Google Scholar 

  29. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Google Scholar 

  30. Fadul CE, Meyer LP, Jobst BC, Cornell CJ, Lewis LD (2002) Agranulocytosis Associated with Lamotrigine in a Patient with Low-grade Glioma. Epilepsia 43(2):199–200

    Article  PubMed  Google Scholar 

  31. Hildebrand J, Lecaille C, Perennes J, Delattre J-Y (2005) Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65:212–215

    Article  PubMed  Google Scholar 

  32. Ieiri I, Morioka T, Kim S, Nishio S, Fukui M, Higuchi S (1996) Pharmacokinetic study of zonisamide in patients undergoing brain surgery. J Pharm Pharmacol 48(12):1270–1275

    PubMed  CAS  Google Scholar 

  33. Khan RB, Hunt DL, Thompson SJ (2004) Gabapentin to control seizures in children undergoing cancer treatment. J Child Neurol 19(2):97–101

    PubMed  Google Scholar 

  34. Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B (2006) Levetiracetam therapy in patients with brain tumor and epilepsy. J Neurooncol 80(1):97–100

    Article  PubMed  CAS  Google Scholar 

  35. Mauro AM, Bomprezzi C, Morresi S, Provinciali L, Formica F, Iacoangeli M, Scerrati M (2007) Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine. J Neurooncol 81(3):279–285

    Article  PubMed  CAS  Google Scholar 

  36. Newton HB, Goldlust SA, Pearl D (2005) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78(1):99–102

    Article  CAS  Google Scholar 

  37. Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 75:255–260

    Article  CAS  Google Scholar 

  38. Perry JR, Sawka C (1996) Add-on Gabapentin for refractory seizures in patients with brain tumors. Can J Neurol Sci 23:128–131

    PubMed  CAS  Google Scholar 

  39. Striano S, Striano P, Boccella P, Noverino C, Bilo L (2002) Tiagabine in glial tumors. Epilepsy Res 49:81–85

    Article  PubMed  CAS  Google Scholar 

  40. Wagner GL, Wilms EB, Van Donselaar CA, Vecht CJ (2003) Levetiracetam: preliminary experience in patients with primary brain tumors. Seizure 12:585–586

    Article  PubMed  CAS  Google Scholar 

  41. Guerrini R, Parmeggiani L (2006) Topiramate in its clinical applications in epilepsy. Expert Opin Pharmacother 7(6):811–823

    Article  PubMed  CAS  Google Scholar 

  42. Guerrini R, Carpay H, Groelj J, Van Oene J, Lahaye M, Schwalen S (2005) Top-Int-51 Investigator’s group. Topiramate monotherapy as broad spectrum antiepileptic in naturalistic clinical setting. Seizure 14:371–380

    PubMed  Google Scholar 

  43. Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B, Carapella CM (2003) Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol 14:1722–1726

    Article  PubMed  CAS  Google Scholar 

  44. Rogers LR, Morris HH, Lupica K (1993) Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy. Neurology 43(8):1599–1601

    PubMed  CAS  Google Scholar 

  45. Smith DF, Hutton JL, Sandemann D, Foy PM, Shaw MD, Williams IR, Chadwick DW (1991) The prognosis of primary intracerebral tumors presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry 54(10):915–920

    Article  PubMed  CAS  Google Scholar 

  46. Warnke PC, Berlis A, Weyerbrock A, Ostertag CB (1997) Significant reduction of seizure incidence and increase of benzodiazepine receptor density after interstitial radiosurgery in low-grade gliomas. Acta Neurochir Suppl 68:90–92

    PubMed  CAS  Google Scholar 

  47. Taylor LP, Posner JB (1989) Phenobarbital rheumatism in patients with brain tumor. Ann Neurol 25(1):92–94

    Article  PubMed  CAS  Google Scholar 

  48. Arvio M, Sillanpää M (2005) Topiramate in long-term treatment of epilepsy in the intellectually disabled. J Intell Dis Res 49:183–189

    Article  CAS  Google Scholar 

  49. Singh BK, White-Scott S (2002) Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities. Seizure 11:47–50

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The Authors want to thank Ms. Lesley Pritikin for reviewing the manuscript

Author information

Authors and Affiliations

  1. Epilepsy Outpatient Center, Department of Neuroscience and Cervical-Facial Pathology, National Institute for Cancer “Regina Elena”, Via Elio Chianesi 53, Roma, 00144, Italy

    M. Maschio, L. Dinapoli, A. Zarabla & B. Jandolo

  2. Department of Neuroscience and Cervical-Facial Pathology, National Institute for Cancer “Regina Elena”, Via Elio Chianesi 53, Roma, 00144, Italy

    M. Maschio, L. Dinapoli, A. Zarabla, A. Pompili, C. M. Carapella, A. Pace, E. Occhipinti & B. Jandolo

  3. Biostatistical Unit, National Institute for Cancer “Regina Elena”, Via Elio Chianesi 53, Roma, 00144, Italy

    D. Giannarelli

Authors
  1. M. Maschio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Dinapoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Zarabla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Pompili
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. M. Carapella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Pace
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Giannarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Occhipinti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. Jandolo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Maschio.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maschio, M., Dinapoli, L., Zarabla, A. et al. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol 86, 61–70 (2008). https://doi.org/10.1007/s11060-007-9430-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-007-9430-3

Keywords

Search

Navigation